Stay updated on Nivolumab Combinations in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the effectiveness comparison of an investigational immunotherapy in combination with other treatments for untreated inoperable or metastatic urothelial cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:21:28.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    7%
    Check dated 2024-05-22T20:30:42.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:25:03.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.